Source: Botica Butler Raudon Partners for The Drug Detection Agency
Opioids and Amphetamines rising in New Zealand Workplaces
AUCKLAND, New Zealand, 29 July 2025 – The Drug Detection Agency (TDDA), New Zealand’s largest workplace drug testing provider, has released its Imperans Q2 2025 workplace drug findings. The data show New Zealand’s workplaces are seeing a rapid increase in opioid use, especially tramadol, and amphetamine-type substances (ATS) are driving regional spikes in positive tests.
The Imperans Report provides New Zealand employers with an analysis of drug usage tr
